To direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8553 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8553 To direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 28, 2026 Mr. Murphy (for himself and Mr. Conaway) introduced the following bill; which was referred to the Committee on Veterans' Affairs _______________________________________________________________________ A BILL To direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026'' or the ``POPCaP Authorization Act of 2026''. SEC. 2. ESTABLISHMENT OF PRECISION ONCOLOGY PROGRAM FOR CANCER OF THE PROSTATE. (a) In General.--Subchapter II of chapter 73 of title 38, United States Code, is amended by adding at the end the following new section: ``Sec. 7330E Precision oncology program for cancer of the prostate ``(a) Establishment.--The Secretary shall establish a precision oncology program for cancer of the prostate (in this section, referred to as the `Program') at the Department in accordance with this section. In carrying out the Program, the Secretary shall-- ``(1) shall designate Centers of Excellence in accordance with subsection (d); and ``(2) maintain the Program Leadership team under subsection (g). ``(b) Eligibility.--A veteran is eligible to enroll in additional medical services through the Program if such veteran is enrolled in the patient enrollment system under section 1705 of this title and has a diagnosis of prostate cancer or non-prostate